Related Experiment Videos
Sodium channels as molecular targets in multiple sclerosis
1Department of Neurology and Paralyzed Veterans of America/Eastern Paralyzed Veterans Association Center for Neuroscience Research, Yale University School of Medicine, New Haven, CT 06510, USA. stephen.waxman@yale.edu
Journal of Rehabilitation Research and Development
|June 8, 2002
Summary
Sodium channels are crucial for nerve signal conduction and are implicated in multiple sclerosis (MS) pathophysiology. Understanding their role may lead to new treatments for MS symptoms and axonal degeneration.
Area of Science:
- Neuroscience
- Cellular Biology
- Pathophysiology
Background:
- Sodium channels are essential for action potential conduction in myelinated axons.
- Multiple sclerosis (MS) involves demyelination, altering sodium channel distribution.
- Altered sodium channel expression is linked to MS symptoms and axonal damage.
Purpose of the Study:
- To explore the role of sodium channels in multiple sclerosis (MS) pathophysiology.
- To investigate sodium channel deployment in remyelination and its contribution to MS remission.
- To examine the potential of targeting sodium channels for symptomatic treatment and neuroprotection in MS.
Main Methods:
- Analysis of sodium channel expression patterns in demyelinated axons.
- Investigation of Purkinje cell sodium channel changes in MS models and patients.
- Examination of sodium channel-mediated axonal injury mechanisms.
Main Results:
- Sodium channel redistribution to demyelinated areas aids action potential restoration and contributes to MS remission.
- Changes in sodium channel expression in Purkinje cells are observed in MS.
- Non-inactivating sodium conductance can induce calcium-mediated axonal injury.
Conclusions:
- Sodium channel dynamics are central to MS pathophysiology, influencing both recovery and symptom generation.
- Targeting specific sodium channel subtypes may offer symptomatic relief for MS-related ataxia.
- Developing strategies to block specific sodium channels could prevent axonal degeneration in MS.